Schistosomiasis Drugs refer to medications used to treat schistosomiasis, a parasitic infection caused by trematode worms from the genus Schistosoma. These drugs target the parasites in the body, helping to eliminate them and alleviate symptoms associated with the infection. The primary drug used for treating schistosomiasis is praziquantel, which is effective against most species of Schistosoma. Other treatments may include oxamniquine and metrifonate, depending on the specific type of schistosomiasis and regional guidelines. These medications work by damaging the parasites' internal structures, leading to their death and subsequent removal from the body.

Schistosomiasis Drugs Market Overview

Schistosomiasis Drugs Market is expected to reach a CAGR of 3.8% during the forecast period 2024-2031

Schistosomiasis, also known as Bilharzia, blood fluke, or Katayama fever, is a disease caused by parasitic worms from the Schistosoma genus. It is transmitted through contact with contaminated water. The Schistosoma parasites are commonly found in rivers, lakes, ponds, swimming pools, municipal water sources, and streams.

Infections in humans are primarily caused by S. haematobium, S. mansoni, and S. japonicum, while S. mekongi and S. intercalatum can also cause illness, though less frequently. Although these parasites are not present in the United States, schistosomiasis affects over 200 million people globally. Transmission can occur through direct contact with infected animals or individuals. As of 2018, schistosomiasis transmission was reported in 78 countries.

Request for free sample:https://www.datamintelligence.com/download-sample/schistosomiasis-drugs-market

Schistosomiasis Drugs Market Trends

The growth of the global schistosomiasis drugs market is driven by factors such as the rising prevalence of schistosomiasis, inadequate healthcare facilities, and a lack of safe drinking water in developing countries.

The increasing incidence of schistosomiasis is a major factor contributing to market growth. Over 140 million people, with 90% residing in Africa, are affected by schistosomiasis. An estimated 700 million people are at risk in 76 countries where the disease is endemic due to exposure to infested water during agricultural, domestic, or recreational activities. Schistosomiasis is responsible for approximately 200,000 deaths annually. While transmission has been interrupted in some regions, the World Health Organization (WHO) estimates that in 2019, around 236.6 million people needed preventive treatment for schistosomiasis, with more than 105.4 million people receiving treatment that year.

Get your customized report @https://www.datamintelligence.com/customize/schistosomiasis-drugs-market

Schistosomiasis Drugs Market is segmented 

By Site:  Intestinal Schistosomiasis, Urogenital Schistosomiasis

By Species Type:  Schistosoma mansoni, Schistosoma japonicum, Schistosoma mekongi, Schistosoma guineensis, Schistosoma haematobium

By Drug Type:  Praziquantel (Biltricide), Oxamniquine (Vansil), Metrifonate, Others

By Distribution Channel:  Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others

By Region:  North America, Latin America, Europe, Asia Pacific, Middle East, and Africa

Schistosomiasis Drugs Market Companies

• Bayer AG
• Merck & Co., Inc.
• Avanscure Lifesciences Pvt. Ltd.
• Shin Poong Pharma.Co., Ltd.
• Egyptian International Pharmaceuticals Industries Co SAE (EIPICO)
• CBC Pharma.
• Chemos GmbH & Co. KG.
• VHB Life Science Inc.
• 3S Corporation Kancera AB
• Taj Pharmaceuticals Ltd.

Related Reports

Bronchiectasis Drugs Market

Schizophrenia Drugs Market 

Osteoporosis Drugs Market

Contact Us:

Company Name: DataM Intelligence

Email: info@datamintelligence.com

Contact Person: Sai. K

Phone: +1 877 441 4866

Website: https://www.datamintelligence.com

About DataM Intelligence:

DataM Intelligence 4Market Research is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. At DataM Intelligence, we leverage our top trademark trends, insights, and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across